APA (7th ed.) Citation

Thomas Kimble, Anne E. Burke, Kurt T. Barnhart, David F. Archer, Enrico Colli, & Carolyn L. Westhoff. (2020). A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen. Elsevier.

Chicago Style (17th ed.) Citation

Thomas Kimble, Anne E. Burke, Kurt T. Barnhart, David F. Archer, Enrico Colli, and Carolyn L. Westhoff. A 1-year Prospective, Open-label, Single-arm, Multicenter, Phase 3 Trial of the Contraceptive Efficacy and Safety of the Oral Progestin-only Pill Drospirenone 4 Mg Using a 24/4-day Regimen. Elsevier, 2020.

MLA (9th ed.) Citation

Thomas Kimble, et al. A 1-year Prospective, Open-label, Single-arm, Multicenter, Phase 3 Trial of the Contraceptive Efficacy and Safety of the Oral Progestin-only Pill Drospirenone 4 Mg Using a 24/4-day Regimen. Elsevier, 2020.